Inicio › Cáncer de pulmón › Florida
Ensayos clínicos de Cáncer de pulmón en Florida
79 estudios sobre Cáncer de pulmón buscan participantes en Florida.
Ciudades en Florida
- Tampa31 estudios
- Orlando23 estudios
- Miami22 estudios
- Jacksonville18 estudios
- Deltona9 estudios
- Gainesville9 estudios
- Hollywood9 estudios
- Fort Lauderdale8 estudios
- Sarasota8 estudios
- Plantation6 estudios
- St. Petersburg6 estudios
- Pembroke Pines5 estudios
- Coral Springs5 estudios
- Largo4 estudios
- Lakeland4 estudios
- Clearwater4 estudios
- Cape Coral4 estudios
- Kendall3 estudios
- Miami Beach3 estudios
- Deerfield Beach3 estudios
- Palm Bay3 estudios
- West Palm Beach3 estudios
- Spring Hill3 estudios
Texto oficial del estudio (inglés)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Boca Raton Clinical Research Coral Springs, Coral Springs
- Regis Clinical Research LLC, Miami
- Florida Clinical Trials Group Tamarac, Tamarac
ReclutandoFase 3
Edades de 18 a 100 · Todos los sexos · Actualizado el 13 nov 2026 · NCT05920356A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Helios Clinical Research - Fort Lauderdale, Fort Lauderdale
- Mayo Clinic in Florida, Jacksonville
- Local Institution - 0523, Tampa
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 nov 2026 · NCT07063745Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-based Chemotherapy With or Without Amivantamab for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- Local Institution - 0142, Pembroke Pines
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07100080This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Mid Florida Hematology and Oncology Center, Orange City
- BRCR Global, Plantation
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06758401Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Morton Plant Hospital, Clearwater
- Miami Cancer Institute, Miami
- South Florida Baptist Hospital, Plant City
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06498635BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Total Health and Research Center, Miami
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07625644Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Holy Cross Hospital, Fort Lauderdale
- Regional Cancer Center-Lee Memorial Health System, Fort Myers
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT04267848Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.
- Bay Pines VA Healthcare System, Bay Pines
- Miami VA Healthcare System, Miami
- James A. Haley Veterans' Hospital, Tampa
Reclutando
Edades de 50 a 80 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07168993Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
- UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- y 13 más
ReclutandoFase 3
Edades de 70 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT06096844A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 12 nov 2026 · NCT07458347A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Mayo Clinic in Florida ( Site 0014), Jacksonville
- Mount Sinai Cancer Center ( Site 0038), Miami Beach
- Mid Florida Hematology and Oncology Center ( Site 0018), Orange City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT06312137A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Hialeah
- GSK Investigational Site, Miami
- GSK Investigational Site, Plantation
- y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07099898Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Clermont Oncology Center, Clermont
- Mid Florida Hematology and Oncology Center, Orange City
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 6 nov 2026 · NCT04198766Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer
- University of Miami, Coral Gables
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06791057A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
- University of Florida, Gainesville
- Mayo Clinic in Florida, Jacksonville
- University of Miami, Miami
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 18 a 100 · Todos los sexos · Actualizado el 5 nov 2026 · NCT05655494A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Florida Cancer Specialists - SOUTH - SCRI - PPDS, Fort Myers
- University of Florida Health at Shands, Gainesville
- BioResearch Partner, Hialeah
- y 6 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 nov 2026 · NCT06793215Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC
- Helios CR, Inc. - The Oncology Institute of Hope and Innovation - Fort Lauderdale, Fort Lauderdale
- Florida Clinical Trials Group, LLC, Plantation
- Florida Clinical Trials Group, Plantation
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07777822Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- y 11 más
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Holy Cross Hospital, Fort Lauderdale
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT04181060VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Holy Cross Hospital (site 213), Fort Lauderdale
- Memorial Cancer Institute at Memorial Healthcare Systems (site 132), Pembroke Pines
ReclutandoFase 1/2
Edades de 18 a 80 · Todos los sexos · Actualizado el 4 nov 2026 · NCT03556228SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
- Florida Cancer Specialists Lake Nona, Orlando
- Florida Cancer Specialists Sarasota, Sarasota
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT07857616A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Millennium Oncology Research Clinic, Hollywood
- Miami Cancer Institute at Baptist Health, Inc., Miami
- Ocala Oncology Center PL DBA Florida Cancer Affiliates - Ocala, Ocala
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 4 nov 2026 · NCT06119581Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- University of Miami, Miami
- Advent Health Orlando, Orlando
- Orlando Health Cancer Institute (Melanoma/NSCLC), Orlando
- y 1 más
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 3 nov 2026 · NCT06060613Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
- Clermont Oncology Center, Clermont
- SSAK Partners, LLC., Coral Springs
- Baptist Medical Center Jacksonville, Jacksonville
- y 4 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06712316Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung
- Orlando Health Cancer Center, Orlando
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07499674Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung Cancer
- Mayo Clinic in Florida, Jacksonville
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 oct 2026 · NCT05746325Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
- Mayo Clinic in Florida, Jacksonville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06918132Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- UF Health Cancer Institute - Gainesville, Gainesville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2026 · NCT06287775A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Orlando
- Research Site, Tampa
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06835569A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 oct 2026 · NCT06172478BRain-AVOidant Proton Craniospinal Irradiation for Leptomeningeal Metastases From Solid Tumor Malignancies
- University of Miami, Miami
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT07789912Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Miami VA Healthcare System, Miami, FL, Miami
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT02984761Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Mayo Clinic Jacksonville, Jacksonville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 oct 2026 · NCT06922591A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Mayo Clinic Jacksonville, Jacksonville
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 oct 2026 · NCT07154290Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Jacksonville, Jacksonville
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 21 oct 2026 · NCT06810544Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Boca Raton Clinical Research Associates, Plantation
- H Lee Moffitt Cancer Center and Research Institute, Tampa
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 19 oct 2026 · NCT06162221AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Orlando
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
ReclutandoFase 1/2
Edades de 18 a 75 · Todos los sexos · Actualizado el 16 oct 2026 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Cancer Care Centers of Brevard, Inc, Palm Bay
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 14 oct 2026 · NCT06712355Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- University of Miami, Miami
- Sarah Cannon Research Institute - Lake Nona Florida, Orlando
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT06293898A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
- D&H Cancer Research Center - Margate, Margate
- Alpha Oncology Research, Orange City
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 oct 2026 · NCT07128199De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.